Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03549468 · ClinicalTrials.gov registry record · NA
The Effect of Low LEVel TrAgus STimulation on the Electrophysiological Substrate of Patients With Ischemic CardioMyopathy Substrate of Subjects With Ischemic CardioMyopathy
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03549468 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 26 participants.
The verdict
NCT03549468, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Patients with ischemic cardiomyopathy (left ventricular ejection fraction \<35%) and heart failure who already have an implantable device with an atrial lead (dual chamber defibrillator or biventricular defibrillator) will undergo sequentially 1. Sham low level tragus stimulation (LLTS) (5min), 2. Active LLTS at 5Hz (15min) and 20Hz (15min) and 3. Active LLTS group with atrial pacing at 100bpm at 5Hz (15min) and 20Hz (15min). The latter is required to examine the effect of LLTS on RA independent of heart rate. Repolarization alternans will be measured by analyzing a regular 12-lead ECG using a custom-made software.
Interventions
- DEVICE Low level tragus stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-05-25 |
| Est. Completion | 2022-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03549468
The ClinicalTrials.gov registry entry for NCT03549468 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low level tragus stimulation is the first listed.
NCT03549468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03549468 about?
NCT03549468 is a clinical study titled "The Effect of Low LEVel TrAgus STimulation on the Electrophysiological Substrate of Patients With Ischemic CardioMyopathy Substrate of Subjects With Ischemic CardioMyopathy". Patients with ischemic cardiomyopathy (left ventricular ejection fraction \<35%) and heart failure who already have an implantable device with an atrial lead (dual chamber defibrillator or biventricular defibrillator) will undergo sequentially 1. Sham low level tragus stimulation (LLTS) (5min), 2. A...
What is the current status of trial NCT03549468?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-05-25. Estimated completion is 2022-03-30.
What interventions are being tested in trial NCT03549468?
The interventions under investigation include: Low level tragus stimulation (DEVICE).
Who is sponsoring clinical trial NCT03549468?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.